• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

EPZM:US

21.9100 USD 0.4400 1.97%

As of 20:10:00 ET on 11/25/2014.

Snapshot for Epizyme Inc (EPZM)

Open: 22.3200 Day's Range: 21.5000 - 22.4100 Volume: 683,633
Previous Close: 22.3500 52wk Range: 18.7500 - 41.2300 1-Yr Rtn: +3.74%

Stock Chart for EPZM

No chart data available.
  • EPZM:US 21.8050
  • 1D
  • 1M
  • 1Y
22.3500
Interactive EPZM Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for EPZM

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.6800
Est. EPS (USD) (12/2014) -1.7530
Est. PEG Ratio -
Market Cap (M USD) 748.52
Shares Outstanding (M) 34.16
30 Day Average Volume 399,595
Price/Book (mrq) 4.3202
Price/Sale (ttm) 9.7859
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 02/27/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for EPZM

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for EPZM

Epizyme, Inc. develops and discovers therapeutics for the treatment of cancer. The Company provides small molecule inhibitors for patients with genetically defined cancers, and inflammatory, metabolic, and neurodegenerative diseases. Epizyme operates in the United States.

Robert J GouldPresident/CEOPeter HoChief Development Officer
Robert A CopelandExec VP/Chief Scientific Ofcr
More Company Profile & Key Executives for EPZM

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil